Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial.

Objectives To investigate the effect of testosterone treatment on biomarkers calprotectin, fibroblast growth factor 23 (FGF23), soluble Klotho, phosphate, calcium, parathyroid hormone, creatinine and estimated glomerular filtration rate.